P-ISSN 2587-2400 | E-ISSN 2587-196X
Ejmo Kapak
EJMO Volume : 6 Issue : 3 Year : 2022
EJMO. 2021; 5(4): 371-373 | DOI: 10.14744/ejmo.2021.65852

Patient on Antithrombotics Drugs: Communication Between the Dentist and the Physician

Saibaba Mahalakshmi1, Suhas Setty1, Hariyabbe Rangaswamy Likhithaswamy2
1Department of Oral Medicine and Radiology, Sri Siddhartha Dental College & Hospital, Sri Siddhartha Academy of Higher Education, Tumkur, Karnataka, India, 2Department of Oral & Maxillofacial Pathology, Sri Siddhartha Academy of Higher Education, Sri Siddhartha Dental College & Hospital, Tumkur, Karnataka, India,

Many dental procedures invariably include a "bleeding event." The chance and severity of such events should be assessed on a relative risk rather than absolute risk. For example, when patients using antithrombotic agents for the management of their systemic illness (like coronary artery disease, cerbero vascular disease and major surgeries like hip joint /knee joint replacement) require any dental treatment, the dentist should weigh bleeding risk associated with the particular dental procedure together with the thrombotic risk. The dentist should also engage with the patient as well as patient`s consulting physician to decide whether the antithrombotic agent needs temporary withdrawal. Physicians, at large are less experienced to correlate the bleeding risks and complications associated with the type and duration of dental procedures which might negatively impact preventive or precautionary recommendations which they may provide


Cite This Article

Mahalakshmi S, Setty S, Likhithaswamy H. Patient on Antithrombotics Drugs: Communication Between the Dentist and the Physician. EJMO. 2021; 5(4): 371-373

Corresponding Author: Saibaba Mahalakshmi

Full Text PDF PDF Download
EJMO & EJMO